Yashwant Pathak – författare

Artificial Neural Network for Drug Design, Delivery and Disposition provides an in-depth look at the use of artificial neural networks (ANN) in pharmaceutical research. With its ability to learn and self-correct in a highly complex environment, this predictive tool has tremendous potential to help researchers more effectively design, develop, and deliver successful drugs.

This book illustrates how to use ANN methodologies and models with the intent to treat diseases like breast cancer, cardiac disease, and more. It contains the latest cutting-edge research, an analysis of the benefits of ANN, and relevant industry examples. As such, this book is an essential resource for academic and industry researchers across the pharmaceutical and biomedical sciences.

Written by leading academic and industry scientists who have contributed significantly to the field and are at the forefront of artificial neural network (ANN) research Focuses on ANN in drug design, discovery and delivery, as well as adopted methodologies and their applications to the treatment of various diseases and disorders Chapters cover important topics across the pharmaceutical process, such as ANN in structure-based drug design and the application of ANN in modern drug discovery Presents the future potential of ANN-based strategies in biomedical image analysis and much more

Artificial Neural Network for Drug Design, Delivery and Disposition provides an in-depth look at the use of artificial neural networks (ANN) in pharmaceutical research. With its ability to learn and self-correct in a highly complex environment, this predictive tool has tremendous potential to help researchers more effectively design, develop, and deliver successful drugs.This book illustrates how to use ANN methodologies and models with the intent to treat diseases like breast cancer, cardiac disease, and more. It contains the latest cutting-edge research, an analysis of the benefits of ANN, and relevant industry examples. As such, this book is an essential resource for academic and industry researchers across the pharmaceutical and biomedical sciences.- Written by leading academic and industry scientists who have contributed significantly to the field and are at the forefront of artificial neural network (ANN) research- Focuses on ANN in drug design, discovery and delivery, as well as adopted methodologies and their applications to the treatment of various diseases and disorders- Chapters cover important topics across the pharmaceutical process, such as ANN in structure-based drug design and the application of ANN in modern drug discovery- Presents the future potential of ANN-based strategies in biomedical image analysis and much more

Nanocarriers for Drug-Targeting Brain Tumors covers different types of nanocarriers and� their design and development for targeting drugs to the brain. The book also presents case studies and the mechanism of action of nanocarriers in drug targeting to a specific site. This helps researchers and clinicians understand the design, development and mechanism of action of nanocarriers. As brain tumors continue to be a significant health problem globally, and very complex for targeting drugs, conventional dosage forms are not very effective and side-effects are a major concern. Functionalized nanocarriers can address these problems.

Furthermore, the targeting of nanocarriers is preferred for reducing toxicity and improving the effectiveness of the drugs. However, there is a need for understanding the design and development of formulation with the mechanism of action of nanocarriers for brain targeting.

Provides information on the design and development of nanocarriers for targeting brain tumors Outlines the working principles of different nanocarriers for targeting brain tumors Includes case studies of different nanocarriers for targeting brain tumors

Nanocarriers for Drug-Targeting Brain Tumors covers different types of nanocarriers and  their design and development for targeting drugs to the brain. The book also presents case studies and the mechanism of action of nanocarriers in drug targeting to a specific site. This helps researchers and clinicians understand the design, development and mechanism of action of nanocarriers. As brain tumors continue to be a significant health problem globally, and very complex for targeting drugs, conventional dosage forms are not very effective and side-effects are a major concern. Functionalized nanocarriers can address these problems.Furthermore, the targeting of nanocarriers is preferred for reducing toxicity and improving the effectiveness of the drugs. However, there is a need for understanding the design and development of formulation with the mechanism of action of nanocarriers for brain targeting.- Provides information on the design and development of nanocarriers for targeting brain tumors- Outlines the working principles of different nanocarriers for targeting brain tumors- Includes case studies of different nanocarriers for targeting brain tumors

Handbook of Lung Targeted Drug Delivery Systems: Recent Trends and Clinical Evidences covers every aspect of the drug delivery to lungs, the physiology and pharmacology of the lung, modelling for lung delivery, drug devices focused on lung treatment, regulatory requirements, and recent trends in clinical applications. With the advent of nano sciences and significant development in the nano particulate drug delivery systems there has been a renewed interest in the lung as an absorption surface for various drugs. The emergence of the COVID-19 virus has brought lung and lung delivery systems into focus, this book covers new developments and research used to address the prevention and treatment of respiratory diseases. Written by well-known scientists with years of experience in the field this timely handbook is an excellent reference book for the scientists and industry professionals.Key Features:Focuses particularly on the chemistry, clinical pharmacology, and biological developments in this field of research.Presents comprehensive information on emerging nanotechnology applications in diagnosing and treating pulmonary diseasesExplores drug devices focused on lung treatment, regulatory requirements, and recent trends in clinical applicationsExamines specific formulations targeted to pulmonary systems

Nanocarriers Based Colon Targeting: Design, Development, Mechanism and Case Studies unveils a groundbreaking exploration of nanotechnology’s potential in revolutionizing drug delivery for colon-related ailments. Today, an array of colonic diseases, including colorectal cancer, colonic polyps, ulcerative colitis, and inflammatory bowel syndrome, pose significant medical challenges. Conventional methods to deliver drugs to this system prove difficult, with limited efficacy and notable side effects. This book delves into the intricate complexities of colonic diseases, their pathophysiology, and epidemiology to support pharmaceutical scientists in designing better drug delivery systems. Providing a comprehensive overview of the area, the chapters elucidate diverse targeting strategies, from time-dependent to microbiota-based drug delivery systems, and explore receptor-based and magnetically assisted delivery mechanisms. Case studies dissected the working mechanisms behind polymeric nanoparticles, polymersomes, polymeric micelles, solid lipid nanoparticles, and other nanocarrier systems tailored for colon targeting. Additionally, this book explores cuttingedge topics such as gold nanoparticles, supra-magnetic iron oxide nanoparticles, and protein-peptide-based nanoparticles, highlighting their mechanisms, applications, and potential toxicities. Merging an overview of colonic pathophysiology with in-depth reviews of each nanomaterial used for drug delivery and practical case studies, Nanocarriers Based Colon Targeting: Design, Development, Mechanism and Case Studies is a complete reference for pharmaceutical scientists involved in elevating drug delivery precision and therapeutic efficacy in this organ system. Toxicologists, material scientists, research physicians, and regulators can also benefit from the case studies developed by expert authors.Introduces different colonic diseases and their pathophysiologyExplains the mechanism of action of different nanocarriers in colon targetingPresents case studies of different nanocarriers in colon targeting

Nanocarriers Based Colon Targeting: Design, Development, Mechanism and Case Studies unveils a groundbreaking exploration of nanotechnology''s potential in revolutionizing drug delivery for colon-related ailments. Today, an array of colonic diseases, including colorectal cancer, colonic polyps, ulcerative colitis, and inflammatory bowel syndrome, pose significant medical challenges. Conventional methods to deliver drugs to this system prove difficult, with limited efficacy and notable side effects. This book delves into the intricate complexities of colonic diseases, their pathophysiology, and epidemiology to support pharmaceutical scientists in designing better drug delivery systems. Providing a comprehensive overview of the area, the chapters elucidate diverse targeting strategies, from time-dependent to microbiota-based drug delivery systems, and explore receptor-based and magnetically assisted delivery mechanisms. Case studies dissected the working mechanisms behind polymeric nanoparticles, polymersomes, polymeric micelles, solid lipid nanoparticles, and other nanocarrier systems tailored for colon targeting. Additionally, this book explores cuttingedge topics such as gold nanoparticles, supra-magnetic iron oxide nanoparticles, and protein–peptide-based nanoparticles, highlighting their mechanisms, applications, and potential toxicities. Merging an overview of colonic pathophysiology with in-depth reviews of each nanomaterial used for drug delivery and practical case studies, Nanocarriers Based Colon Targeting: Design, Development, Mechanism and Case Studies is a complete reference for pharmaceutical scientists involved in elevating drug delivery precision and therapeutic efficacy in this organ system. Toxicologists, material scientists, research physicians, and regulators can also benefit from the case studies developed by expert authors.- Introduces different colonic diseases and their pathophysiology- Explains the mechanism of action of different nanocarriers in colon targeting- Presents case studies of different nanocarriers in colon targeting

Drug Delivery Landscape in Cancer Research examines the combined impact of prevention, diagnosis, and treatment of cancer. With a strong focus on the status, challenges, and prospects of cancer drug delivery technology, the book examines clinical translation-related knowledge and the development of different organ related cancers. In 22 chapters, it describes current and new drug delivery systems in twenty different cancers and gives insights into drug delivery strategies and tumor microenvironment management in oral and ocular cancers. This book is a timely and valuable resource for health professionals, scientists, researchers, health practitioners, students, and anyone who wants to broaden their knowledge.Contains current studies of the targeted use of drug delivery systems based on the microenvironmental properties of different cancer typesProvides essential information on the most recent drug delivery systems available for different cancer typesExplains current technology and its applications to drug delivery in cancerContains contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers

Drug Delivery Landscape in Cancer Research examines the combined impact of prevention, diagnosis, and treatment of cancer. With a strong focus on the status, challenges, and prospects of cancer drug delivery technology, the book examines clinical translation-related knowledge and the development of different organ related cancers. In 22 chapters, it describes current and new drug delivery systems in twenty different cancers and gives insights into drug delivery strategies and tumor microenvironment management in oral and ocular cancers. This book is a timely and valuable resource for health professionals, scientists, researchers, health practitioners, students, and anyone who wants to broaden their knowledge.- Contains current studies of the targeted use of drug delivery systems based on the microenvironmental properties of different cancer types- Provides essential information on the most recent drug delivery systems available for different cancer types- Explains current technology and its applications to drug delivery in cancer- Contains contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers

Cancer, a multifaceted disease, remains the leading cause of death worldwide. Ongoing research and technological advancements are continually improving the human understanding of newer treatment options. This book series aims to provide wide-ranging insights into the current landscape of cancer research, highlighting the recent advancements, current challenges, and future directions. Cancer varies widely in its formation, microenvironment, location in the body, associated risk factors, detection methodology, and treatment approaches. Early detection and prevention through lifestyle changes, regular screenings, and the awareness of symptoms are crucial for improving outcomes and survival rates. In this book series, the main focus is on trending topics, like new drug delivery, diagnostics, biomarkers, and preclinical and clinical developments in cancer research. Nanotechnology has emerged as a transformative approach in medicine, particularly in the areas of targeted drug delivery systems, imaging, and diagnostics to enhance the therapeutic efficacy and minimize adverse effects in cancer therapy. Advances in pharma, medical device, and diagnostic research, including the development of Trojan-horse therapies and precision treatments/assay kits, continue to enhance the effectiveness of cancer care over the past few decades. A total of five books are covered in this series: Drug Delivery Landscape in Cancer Research (Vol. 1)Biomarker Landscape in Cancer Research (Vol. 2)Diagnostic Landscape in Cancer Research (Vol. 3)Preclinical Landscape in Cancer Research (Vol. 4)Clinical Landscape in Cancer Research (Vol. 5) By integrating basic, applied, and innovative science concepts, this book series fosters a deeper understanding of the disease and paves the way for the development of more effective strategies. This book series serves as a valuable resource for students, researchers, regulators, and clinicians interested in understanding the complexities of cancer and the innovative approaches researched to combat this deadly disease. Nonetheless, continuous interdisciplinary, cross-country collaborations and cross-science innovation strategies are essential to further reduce the global cancer burden.Contains current studies of the clinical research of different cancer typesProvides essential information on the most recent developments in clinical cancer researchExplains current technology and its applications of clinical cancer researchHolds contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers

Cancer, a multifaceted disease, remains the leading cause of death worldwide. Ongoing research and technological advancements are continually improving the human understanding of newer treatment options. This book series aims to provide wide-ranging insights into the current landscape of cancer research, highlighting the recent advancements, current challenges, and future directions. Cancer varies widely in its formation, microenvironment, location in the body, associated risk factors, detection methodology, and treatment approaches. Early detection and prevention through lifestyle changes, regular screenings, and the awareness of symptoms are crucial for improving outcomes and survival rates. In this book series, the main focus is on trending topics, like new drug delivery, diagnostics, biomarkers, and preclinical and clinical developments in cancer research. Nanotechnology has emerged as a transformative approach in medicine, particularly in the areas of targeted drug delivery systems, imaging, and diagnostics to enhance the therapeutic efficacy and minimize adverse effects in cancer therapy. Advances in pharma, medical device, and diagnostic research, including the development of Trojan-horse therapies and precision treatments/assay kits, continue to enhance the effectiveness of cancer care over the past few decades. A total of five books are covered in this series:- Drug Delivery Landscape in Cancer Research (Vol. 1)- Biomarker Landscape in Cancer Research (Vol. 2)- Diagnostic Landscape in Cancer Research (Vol. 3)- Preclinical Landscape in Cancer Research (Vol. 4)- Clinical Landscape in Cancer Research (Vol. 5) By integrating basic, applied, and innovative science concepts, this book series fosters a deeper understanding of the disease and paves the way for the development of more effective strategies. This book series serves as a valuable resource for students, researchers, regulators, and clinicians interested in understanding the complexities of cancer and the innovative approaches researched to combat this deadly disease. Nonetheless, continuous interdisciplinary, cross-country collaborations and cross-science innovation strategies are essential to further reduce the global cancer burden.- Contains current studies of the clinical research of different cancer types- Provides essential information on the most recent developments in clinical cancer research- Explains current technology and its applications of clinical cancer research- Holds contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers

Preclinical Cancer Landscape discusses the issues in preclinical-to-clinical translatability of molecularly targeted cancer therapies and the need to better align tumour biology in patients With a strong focus on the status, challenges, prospects and the need of robustness of preclinical cancer research, the book acknowledges that the bar for reproducibility in performing and presenting preclinical studies must be raised to facilitate a transparent discovery process that frequently and consistently leads to significant patient benefit. In 22 chapters this book describes the current status of preclinical research in multiple cancers. This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field. " Preclinical landscape in cancer research " is written by experts in the field and informed with facts directly from manufacturers. Pharmaceutical scientists, medical researchers, biomedical engineers and clinical professionals will find this an essential reference.Contains current studies of the preclinical research of 25 different cancer typesProvides essential information on the most recent developments in preclinical cancer researchExplains current technology and its applications of preclinical cancer researchHolds contributions from oncologists, biomedical engineers, pharmaceutical scientists and manufacturers

Preclinical Cancer Landscape discusses the issues in preclinical-to-clinical translatability of molecularly targeted cancer therapies and the need to better align tumour biology in patients With a strong focus on the status, challenges, prospects and the need of robustness of preclinical cancer research, the book acknowledges that the bar for reproducibility in performing and presenting preclinical studies must be raised to facilitate a transparent discovery process that frequently and consistently leads to significant patient benefit. In 22 chapters this book describes the current status of preclinical research in multiple cancers. This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field. " Preclinical landscape in cancer research " is written by experts in the field and informed with facts directly from manufacturers. Pharmaceutical scientists, medical researchers, biomedical engineers and clinical professionals will find this an essential reference.- Contains current studies of the preclinical research of 25 different cancer types- Provides essential information on the most recent developments in preclinical cancer research- Explains current technology and its applications of preclinical cancer research- Holds contributions from oncologists, biomedical engineers, pharmaceutical scientists and manufacturers

Nanotherapeutics for Treating Neurodegenerative Disorders is a comprehensive guide to the cutting edge field of nanotherapeutics. This book reviews the complex landscape of neurodegenerative disorders, outlining the nuances of treatment strategies and the imperative role of nanotechnology in revolutionizing therapeutic interventions. From explaining the transport mechanisms of the blood-brain barrier to unveiling the therapeutic potential of stem cell-derived nanocarriers, each chapter offers invaluable insights into the diverse array of nanotherapeutic approaches, helping to reshape the landscape of neurological healthcare. This book provides a comprehensive resource for clinicians, researchers, and students in the fields of neurology and nanotherapeutics.. Reviews the complexities of treatment strategies and the transformative role of nanotechnology in reshap ing therapeutic interventions. Offers a diverse array of insights, providing readers with invaluable knowledge across a spectrum of nano therapeutic approaches. Provides current updates on advanced target-based nanotherapeutics

Nanotherapeutics for Treating Neurodegenerative Disorders is a comprehensive guide to the cutting edge field of nanotherapeutics. This book reviews the complex landscape of neurodegenerative disorders, outlining the nuances of treatment strategies and the imperative role of nanotechnology in revolutionizing therapeutic interventions. From explaining the transport mechanisms of the blood-brain barrier to unveiling the therapeutic potential of stem cell-derived nanocarriers, each chapter offers invaluable insights into the diverse array of nanotherapeutic approaches, helping to reshape the landscape of neurological healthcare. This book provides a comprehensive resource for clinicians, researchers, and students in the fields of neurology and nanotherapeutics.* Reviews the complexities of treatment strategies and the transformative role of nanotechnology in reshap ing therapeutic interventions* Offers a diverse array of insights, providing readers with invaluable knowledge across a spectrum of nano therapeutic approaches* Provides current updates on advanced target-based nanotherapeutics

Diagnostic Landscape in Cancer Landscape examines the combined impact of prevention, diagnosis, and treatment of cancer. With a strong focus on the status, challenges, and prospects of diagnostic tools and technology, the book also examines the clinical translation-related knowledge and prognosis of different organ related cancers. In 22 chapters, the book describes current and new diagnostic tools in twenty different cancers and explores how innovations in the cancer diagnostic space could make cancer screening and early detection more straightforward.This book is a timely and valuable resource for health professionals, scientists, researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.Provides essential information on the most recent developments in the diagnostic landscape of different cancer typesExplains current technology and its applications in the diagnostic cancer research landscapeIncludes contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers

Diagnostic Landscape in Cancer Landscape examines the combined impact of prevention, diagnosis, and treatment of cancer. With a strong focus on the status, challenges, and prospects of diagnostic tools and technology, the book also examines the clinical translation-related knowledge and prognosis of different organ related cancers. In 22 chapters, the book describes current and new diagnostic tools in twenty different cancers and explores how innovations in the cancer diagnostic space could make cancer screening and early detection more straightforward.This book is a timely and valuable resource for health professionals, scientists, researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.- Provides essential information on the most recent developments in the diagnostic landscape of different cancer types- Explains current technology and its applications in the diagnostic cancer research landscape- Includes contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers

Biomarker Landscape in Cancer Research examines the impact of early detection, predication of aggressiveness, and the determination of the best treatment for cancers. With a strong focus on the status, challenges, and prospects of biomarker measurements' tools and technology, the book also examines clinical translation-related knowledge and the prognosis of different organ related cancers. In 21 chapters, it describes current and new diagnostic tools in twenty different cancers and explores how innovations in the cancer diagnostic space could make cancer screening and early detection more straightforward.This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.Provides essential information on the most recent developments in the biomarker landscape of different cancer typesExplains current technologies and their applications in the biomarker cancer research landscapeIncludes contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers

Biomarker Landscape in Cancer Research examines the impact of early detection, predication of aggressiveness, and the determination of the best treatment for cancers. With a strong focus on the status, challenges, and prospects of biomarker measurements'' tools and technology, the book also examines clinical translation-related knowledge and the prognosis of different organ related cancers. In 21 chapters, it describes current and new diagnostic tools in twenty different cancers and explores how innovations in the cancer diagnostic space could make cancer screening and early detection more straightforward.This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field.- Provides essential information on the most recent developments in the biomarker landscape of different cancer types- Explains current technologies and their applications in the biomarker cancer research landscape- Includes contributions from oncologists, biomedical engineers, pharmaceutical scientists, and manufacturers

Tumor Microenvironment provides an in-depth exploration of the intricate relationships between various cancers and their respective tumor microenvironments. Each chapter focuses on a specific type of cancer, detailing the unique characteristics of its microenvironment, including the roles of immune cells, stromal components, and extracellular matrix. The book highlights advancements in research, diagnostic techniques, and therapeutic strategies aimed at targeting the tumor microenvironment, offering valuable insights into potential future directions in cancer treatment. By presenting cutting-edge information and real-world applications, this book helps readers understand cancer biology while also fostering innovative approaches to research and clinical practice that contribute to improved patient outcomes.Provides an extensive examination of the tumor microenvironment across various cancer types, offering detailed insights into the unique cellular and molecular interactionsHighlights current advancements in cancer research, including novel diagnostic techniques and emerging therapeutic strategies that target the tumor microenvironmentIncorporates real-world case studies and practical examples, allowing readers to understand the implications of theoretical concepts in clinical settingsEncourages the application of new strategies to improve patient care in oncology

Tumor Microenvironment provides an in-depth exploration of the intricate relationships between various cancers and their respective tumor microenvironments. Each chapter focuses on a specific type of cancer, detailing the unique characteristics of its microenvironment, including the roles of immune cells, stromal components, and extracellular matrix. The book highlights advancements in research, diagnostic techniques, and therapeutic strategies aimed at targeting the tumor microenvironment, offering valuable insights into potential future directions in cancer treatment. By presenting cutting-edge information and real-world applications, this book helps readers understand cancer biology while also fostering innovative approaches to research and clinical practice that contribute to improved patient outcomes. - Provides an extensive examination of the tumor microenvironment across various cancer types, offering detailed insights into the unique cellular and molecular interactions- Highlights current advancements in cancer research, including novel diagnostic techniques and emerging therapeutic strategies that target the tumor microenvironment- Incorporates real-world case studies and practical examples, allowing readers to understand the implications of theoretical concepts in clinical settings- Encourages the application of new strategies to improve patient care in oncology

Emerging Trends in Cancer Research provides a comprehensive and up-to-date exploration of the latest advancements in cancer therapeutics, diagnostics, and intellectual property landscapes. Each chapter delves into the specific aspects of different cancers, offering insights into drug resistance mutations, biomarker trends, preclinical model updates, and clinical pipeline developments. The book also addresses the importance of diagnostics and the evolving landscape of intellectual property in cancer treatment. Sections analyze cancer drug resistance mutations, biomarker trends, and diagnostics across various cancers, including intestinal, cardiac, brain, and blood cancers.Readers will find coverage of clinical pipeline developments, intellectual property landscapes, and advancements in cancer therapeutics, diagnostics, and global drug delivery trends. This book is an invaluable resource for oncology, biomedical engineering, and pharmaceutical professionals, offering insights into the latest cancer research trends. It includes real-world case studies, practical applications, and discussions on regulatory and ethical considerations, making it essential for both seasoned researchers and graduate students.Provides comprehensive, up-to-date insights into the latest advancements in cancer therapeutics, diagnostics, and intellectual property landscapes, covering a wide range of cancers (intestinal, cardiac, brain, and blood cancers)Delivers detailed analyses of drug resistance mutations, biomarker trends, preclinical model updates, and clinical pipeline developmentsIncludes real-world case studies and practical applications, along with discussions on regulatory and ethical considerations

Emerging Trends in Cancer Research provides a comprehensive and up-to-date exploration of the latest advancements in cancer therapeutics, diagnostics, and intellectual property landscapes. Each chapter delves into the specific aspects of different cancers, offering insights into drug resistance mutations, biomarker trends, preclinical model updates, and clinical pipeline developments. The book also addresses the importance of diagnostics and the evolving landscape of intellectual property in cancer treatment. Sections analyze cancer drug resistance mutations, biomarker trends, and diagnostics across various cancers, including intestinal, cardiac, brain, and blood cancers.Readers will find coverage of clinical pipeline developments, intellectual property landscapes, and advancements in cancer therapeutics, diagnostics, and global drug delivery trends. This book is an invaluable resource for oncology, biomedical engineering, and pharmaceutical professionals, offering insights into the latest cancer research trends. It includes real-world case studies, practical applications, and discussions on regulatory and ethical considerations, making it essential for both seasoned researchers and graduate students. - Provides comprehensive, up-to-date insights into the latest advancements in cancer therapeutics, diagnostics, and intellectual property landscapes, covering a wide range of cancers (intestinal, cardiac, brain, and blood cancers)- Delivers detailed analyses of drug resistance mutations, biomarker trends, preclinical model updates, and clinical pipeline developments- Includes real-world case studies and practical applications, along with discussions on regulatory and ethical considerations

Drug Repurposing in Cancer Research investigates the innovative use of drug repurposing in oncology, focusing on emerging and re-emerging cancer types. The book provides a comprehensive yet concise overview of current trends, making it an essential resource for academics and professionals in the field. Structured into 21 chapters, the book presents foundational facts alongside practical and clinically relevant data. It covers topics ranging from market dynamics to AI-driven transformations in cancer treatment, highlighting the rapid advancements in oncology. This compilation ensures that readers are equipped with the latest information necessary for effective research and development. For pharmaceutical researchers, biomedical scientists, and clinicians, "Drug Repurposing in Cancer Research" offers valuable insights into the growing demand for innovative cancer treatments. It serves as a timely resource for understanding the potential of repurposed drugs, supporting efforts in cancer prevention and treatment strategies.Provides a thorough yet concise examination of current trends in drug repurposing and theranostics within oncologyOffers foundational facts alongside actionable insights, supporting effective research and clinical applicationsHighlights the rapid advancements and market dynamics in cancer treatment, ensuring readers stay informed about the latest developments

Biosimilars in Cancer is a comprehensive resource on the role of biosimilars in treating various cancer types. The book offers a succinct yet thorough overview of current trends in oncology, covering 21 different cancers from liver to breast cancer. Chapters provide detailed insights into trends, fundamental facts, and practical and clinical data, making it an invaluable tool for academics and practitioners. The book empowers researchers and clinicians to enhance understanding and improve patient outcomes through the effective use of biosimilars in oncology. Targeted primarily at pharmaceutical researchers, biomedical scientists, and clinicians, it supports the growing oncology biosimilars market.In addition, the book provides critical insights for those involved in cancer diagnostics and clinical trials, helping them stay ahead in this rapidly progressing field.Offers detailed information on 21 different cancer types, ensuring a broad understanding of biosimilar applications in oncologyPresents up-to-date insights into the rapidly evolving field of cancer treatment, helping researchers and clinicians stay aheadIntegrates fundamental facts with practical and clinically relevant data, making it a valuable resource for academic and clinical purposes

Developments and Recent Trends in Cell and Gene Therapies for Cancer is a comprehensive and strategic reference that explores the scientific foundations, clinical applications, and commercial success of FDA-approved cell and gene therapies. Each chapter focuses on a specific FDA-approved cell or gene therapy product, detailing its development journey, mechanism of action, therapeutic indications, clinical outcomes, regulatory approval, visual data (minimum 4 figures and 3 tables per chapter) and real-world outcomes. The therapies span a wide range of modalities including CAR-T cells, cord blood-derived products, gene editing technologies, and viral vector-based treatments. The chapters are authored by subject matter experts from academia, clinical institutions, and industry, ensuring authoritative and up-to-date content. With contributions from leading experts in academia and industry, the book highlights innovations in CAR-T, cord blood, and gene editing technologies, featuring therapies from companies such as Bristol-Myers Squibb, Pfizer, and Janssen. Designed with modular chapters and rich visual content, it serves both as a scientific resource and a practical guide for oncologists, researchers, biotech professionals, and regulatory stakeholders navigating the evolving landscape of cancer treatment.Focuses on a single FDA-approved therapy, offering a consistent and detailed format that includes development history, mechanism of action, clinical indications, and outcomes-making it easy for readers to find targeted, actionable insightsBridges foundational science with commercialization pathways, regulatory considerations, and translational challenges-ideal for both researchers and biotech professionalsEnsures authoritative content and diverse perspectives, enhancing its value as a reference for oncology, drug development, and policy-making

This groundbreaking Theranostic book delivers the definitive roadmap for the next generation of precision oncology by systematically detailing the clinical, regulatory, and drug delivery landscapes of theranostics-the revolutionary integration of therapy and diagnostics-across 20-22 major cancer types. Designed for medical publishers, clinicians, and biotech researchers, this chapter is a structural framework for each malignancy, bridging laboratory breakthroughs in nanotechnology, green nanochemistry, drug delivery, diagnostics, and AI with real-world clinical applications. It serves as an essential commercial and academic asset, offering unprecedented depth on FDA/EMA regulatory hurdles, technology transfer pathways, and actionable data tables that track active clinical trials and global research groups. By addressing key market trends and regulatory challenges, it serves as an essential, multidisciplinary resource for driving personalized oncology and improving patient outcomesHigh-Value Cancer-Specific Market Intel: Analyses the complete theranostic landscape across distinct global cancer marketsEnd-to-End Translational Roadmap: Connects cutting-edge nanomedicine, green nanotechnology, nanodiamonds, and AI-driven diagnostics directly to practical FDA/EMA regulatory processes and technology transfer workflowsReady-to-Use Clinical & Research Data: Provides a comprehensive reference suite for tracking ongoing clinical trials, preclinical models, patents, and R&D insights

Today we find the applications of nanotechnology in all spheres of life. Nanotechnology: Therapeutic, Nutraceutical and Cosmetic Advances discusses recent advances in the field, particularly with therapeutics, nutraceuticals and cosmetic sciences.Therapeutics is an area which has perhaps benefitted the most, although nanoscience and technology have quietly entered the realms of food science and are playing pivotal roles in the efficient utilization of nutraceuticals. Finally, even before therapeutics came cosmetics and companies started marketing unique products embedding the beneficial and advanced properties enabled by the use of nanostructures. This book highlights trends and applications of this wonderful new technology.

This unique volume in our Drugs and Pharmaceutical Sciences series covers the development of gene therapy today, the technology involved, clinical applications of siRNA, non-viral vector-based mRNA delivery using nanotechnology, and RNA based vaccines for treating the infectious diseases. It also presents the current application of the CRISPR/Cas9 gene-editing technique which has revolutionized genome editing and which was awarded the 2020 Nobel Prize in Chemistry. Several new drug delivery systems are explored for the applications of gene therapy. These are found to be useful in treating chronic illnesses, including cancer and infectious diseases. Key Features: Overview of the development of gene therapy Provides the most up to date information on the development of gene therapy, from the technology involved to gene correction and genome editing Presents CRISPR gene therapy recent trends and applications Discusses siRNA, mRNA, and DNA plasmids